| |
Bristol wins U.S. approval for single anti-HIV pill
NEW YORK (Reuters) - Bristol-Myers Squibb Co. said on Friday that U.S. regulators approved a single-capsule form of its Reyataz HIV drug to be taken as part of combination drug therapy.
Publ.Date : Fri, 20 Oct 2006 18:45:30 GMT
Blocking an enzyme curbs colon cancer, in mice
NEW YORK (Reuters Health) - Blocking the enzyme aldose reductase prevents proliferation of human colon cancer cells and arrests tumor progression in mice, researchers report in the journal Cancer Research.
Publ.Date : Fri, 20 Oct 2006 18:27:42 GMT
|
|
|
